Liver Cirrhosis
Diabetes Risk Associated with Hepatitis C Infection and Alcoholic Liver Disease
Published in Hepatitis Weekly, April 10th, 2000
Patients with end-stage liver cirrhosis due to hepatitis C infection or alcoholic liver disease are at increased risk for developing diabetes, according to Mayo Clinic researchers. determine the prevalence of diabetes mellitus in end-stage liver cirrhosis patients whose disease was the result of either HCV or cholestatic liver disease, determine if viral and/or immunogenetic factors make the patient more susceptible to diabetes, assess outcome of...
They also reported that liver transplantation outcome and survival was not affected by being diabetic.
N.N. Zein and colleagues had a three-pronged goal for their study:
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2000-04-10)
More Articles from Hepatitis Weekly
- Therapy (HBV)
Lipid Carrier Delivers Drug to Liver Cells - Diagnostics
HBV System Has Sensitivity of PCR with Quantitation of Hybrid Testing - Etiology
Hepatitis G May Not Be Hepatitis at All - Liver Cancer
TT Virus May Not Influence Disease Progression - Liver Disease
Lack of Enzyme Seen in Patients with Hepatic Dysfunction - NIH Grant News
Passive and Active Immunoprophylaxis Pursued for Hepatitis Prevention - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
